Renal cell carcinoma guideline

被引:469
作者
Ljungberg, Borje [1 ]
Hanbury, Damian C.
Kuczyk, Marcus A.
Merseburger, Axel S.
Mulders, Peter F. A.
Patard, Jean-Jacques
Sinescu, Ioanel C.
机构
[1] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, S-90185 Umea, Sweden
[2] Lister Hosp, Dept Urol, Stevenage, Herts, England
[3] Univ Tubingen, Dept Urol, Tubingen, Germany
[4] Radboud Univ Nijmegen, Med Ctr, Dept Urol, Nijmegen, Netherlands
[5] CHU Pontchaillou, Dept Urol, Rennes, France
[6] Fundeni Clin Inst, Dept Urol & Kidney Transplantat, Bucharest, Romania
关键词
diagnosis; follow-up; recommendations; guidelines; renal cell carcinoma; treatment;
D O I
10.1016/j.eururo.2007.03.035
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The European Association of Urology (EAU) Guideline Group for renal cell carcinoma (RCC) prepared this guideline to help urologists assess the evidence-based management of RCC and to incorporate the guideline recommendations into their clinical practice. Methods: The recommendations provided in the current guideline are based on a systematic literature search using Medline, the Cochrane Central Register of Controlled Trials, and publications and review articles. Results: A limited number of prospective randomised. studies are available with high-level evidence. Most publications concerning RCC are based on retrospective analyses, including some larger multicentre validation studies and well-designed controlled studies. Conclusions: It must be stressed that the current guideline contains information for the treatment of an individual patient according to a standardised general approach. Updated recommendations concerning diagnosis, treatment, and follow-up can improve the clinical handling of patients with RCC. (C) 2007 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1502 / 1510
页数:9
相关论文
共 65 条
  • [1] Randomized phase II/III trial of interferon alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell carcinoma:: The European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951)
    Aass, N
    De Mulder, PHM
    Mickisch, GHJ
    Mulders, P
    van Oosterom, AT
    van Poppel, H
    Fossa, SD
    de Prijck, L
    Sylvester, RJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) : 4172 - 4178
  • [2] Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
    Andrews, DW
    Scott, CB
    Sperduto, PW
    Flanders, AE
    Gaspar, LE
    Schell, MC
    Werner-Wasik, M
    Demas, W
    Ryu, J
    Bahary, JP
    Souhami, L
    Rotman, M
    Mehta, MP
    Curran, WJ
    [J]. LANCET, 2004, 363 (9422) : 1665 - 1672
  • [3] [Anonymous], [No title captured]
  • [4] [Anonymous], EUR VERS 4 0 EUR INC
  • [5] IL-2 in combination with IFN-α and 5-FU versus tamoxifen in metastatic renal cell carcinoma:: long-term results of a controlled randomized clinical trial
    Atzpodien, J
    Kirchner, H
    Illiger, HJ
    Metzner, B
    Ukena, D
    Schott, H
    Funke, PJ
    Gramatzki, M
    von Jürgensom, S
    Wandert, T
    Patzelt, T
    Reitz, M
    [J]. BRITISH JOURNAL OF CANCER, 2001, 85 (08) : 1130 - 1136
  • [6] Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma:: Long-term survival data of 216 patients
    Becker, F
    Siemer, S
    Humke, U
    Hack, M
    Ziegler, M
    Stöckle, M
    [J]. EUROPEAN UROLOGY, 2006, 49 (02) : 308 - 313
  • [7] Morphologic typing of papillary renal cell carcinoma: Comparison of growth kinetics and patient survival in 66 cases
    Delahunt, B
    Eble, JN
    McCredie, MRE
    Bethwaite, PB
    Stewart, JH
    Bilous, AM
    [J]. HUMAN PATHOLOGY, 2001, 32 (06) : 590 - 595
  • [8] Eble JN, 2004, PATHOLOGY GENETICS T, P7
  • [9] Sorafenib in advanced clear-cell renal-cell carcinoma
    Escudier, Bernard
    Eisen, Tim
    Stadler, Walter M.
    Szczylik, Cezary
    Oudard, Stephane
    Siebels, Michael
    Negrier, Sylvie
    Chevreau, Christine
    Solska, Ewa
    Desai, Apurva A.
    Rolland, Frederic
    Demkow, Tomasz
    Hutson, Thomas E.
    Gore, Martin
    Freeman, Scott
    Schwartz, Brian
    Shan, Minghua
    Simantov, Ronit
    Bukowski, Ronald M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) : 125 - 134
  • [10] Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma
    Ficarra, V
    Schips, L
    Guillé, F
    Li, GR
    De la Taille, A
    Galetti, TP
    Cindolo, L
    Novara, G
    Zigeuner, RE
    Bratti, E
    Tostain, J
    Altieri, V
    Abbou, CC
    Artibani, W
    Patard, JJ
    [J]. CANCER, 2005, 104 (05) : 968 - 974